05/28/2024
6:14 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
05/20/2024
3:16 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form F-1/A | |
05/20/2024
8:02 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
8:02 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
9:21 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
04/10/2024
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:32 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/08/2024
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/05/2024
8:28 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
4:10 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/04/2024
3:31 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/04/2024
3:37 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
02/22/2024
7:25 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024
12:20 PM | Gordon Ariel (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/13/2024
9:14 AM | Ben-Noon Alon (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/07/2024
8:38 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:48 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
7:49 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:01 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
4:03 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/21/2023
7:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
3:30 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/14/2023
8:41 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023
2:00 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023
2:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023
7:01 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/04/2023
5:17 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
11/28/2023
8:00 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023
9:36 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
11/13/2023
8:28 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023
7:35 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023
7:45 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
8:12 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023
10:39 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
4:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Trump’s arrest is phase one (Ad) In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America.
It’s not just about blocking Trump’s re-election…  To get all the details, go here now. |
09/20/2023
8:16 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
8:15 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
8:20 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023
3:31 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
09/05/2023
11:15 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
07/21/2023
3:27 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
07/06/2023
7:30 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2023
1:09 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/23/2023
3:05 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
06/23/2023
3:06 PM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/22/2023
5:12 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
06/13/2023
7:30 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023
8:16 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
7:50 AM | NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
